Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 224

1.

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.

Brooks S, Jacobs GE, de Boer P, Kent JM, Van Nueten L, van Amerongen G, Zuiker R, Kezic I, Luthringer R, van der Ark P, van Gerven JM, Drevets W.

J Psychopharmacol. 2019 Feb;33(2):202-209. doi: 10.1177/0269881118822258. Epub 2019 Jan 15.

PMID:
30644312
2.

State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis?

De Picker L, Ottoy J, Verhaeghe J, Deleye S, Wyffels L, Fransen E, Kosten L, Sabbe B, Coppens V, Timmers M, de Boer P, Van Nueten L, Op De Beeck K, Oberacher H, Vanhoenacker F, Ceyssens S, Stroobants S, Staelens S, Morrens M.

Brain Behav Immun. 2019 Mar;77:46-54. doi: 10.1016/j.bbi.2018.11.318. Epub 2018 Nov 29.

PMID:
30503836
3.

Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression: Effects on cognitive functioning.

Niemegeers P, de Boer P, Schuermans J, Dumont GJH, Coppens V, Spittaels K, Claes S, Sabbe BGC, Morrens M.

J Affect Disord. 2019 Feb 15;245:356-363. doi: 10.1016/j.jad.2018.11.020. Epub 2018 Nov 6.

PMID:
30423462
4.

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants.

Timmers M, Ravenstijn P, Xi L, Triana-Baltzer G, Furey M, Van Hemelryck S, Biewenga J, Ceusters M, Bhattacharya A, van den Boer M, van Nueten L, de Boer P.

J Psychopharmacol. 2018 Dec;32(12):1341-1350. doi: 10.1177/0269881118800067. Epub 2018 Sep 27.

PMID:
30260294
5.

Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.

van der Ark PD, Golor G, van Nueten L, Nandy P, de Boer P.

J Psychopharmacol. 2018 Dec;32(12):1330-1340. doi: 10.1177/0269881118791521. Epub 2018 Sep 5.

PMID:
30182786
6.

Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network.

Mueller F, Musso F, London M, de Boer P, Zacharias N, Winterer G.

Neuroimage Clin. 2018 Jun 1;19:745-757. doi: 10.1016/j.nicl.2018.05.037. eCollection 2018.

7.

Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder.

van den Ameele S, Fuchs D, Coppens V, de Boer P, Timmers M, Sabbe B, Morrens M.

Front Psychiatry. 2018 Jun 14;9:250. doi: 10.3389/fpsyt.2018.00250. eCollection 2018.

8.

Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre study.

Thomeer MG, Vandecaveye V, Braun L, Mayer F, Franckena-Schouten M, de Boer P, Stoker J, Van Limbergen E, Buist M, Vergote I, Hunink M, van Doorn H.

Eur Radiol. 2019 Jan;29(1):309-318. doi: 10.1007/s00330-018-5510-3. Epub 2018 Jun 25.

9.

A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity.

De Boer P, Drevets WC, Rofael H, van der Ark P, Kent JM, Kezic I, Parapatics S, Dorffner G, van Gerven J, Beneš H, Keicher C, Jahn H, Seiden DJ, Luthringer R.

J Psychopharmacol. 2018 Jun;32(6):668-677. doi: 10.1177/0269881118773745. Epub 2018 May 31.

PMID:
29848147
10.

Treatment-resistant depression and peripheral C-reactive protein.

Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET.

Br J Psychiatry. 2019 Jan;214(1):11-19. doi: 10.1192/bjp.2018.66. Epub 2018 May 16.

11.

Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.

de Boer P, van de Schoot AJAJ, Westerveld H, Smit M, Buist MR, Bel A, Rasch CRN, Stalpers LJA.

Strahlenther Onkol. 2018 Mar;194(3):255-263. doi: 10.1007/s00066-017-1224-8. Epub 2017 Nov 3.

12.

Nanoparticle discrimination based on wavelength and lifetime-multiplexed cathodoluminescence microscopy.

Garming MWH, Weppelman IGC, de Boer P, Martínez FP, Schirhagl R, Hoogenboom JP, Moerland RJ.

Nanoscale. 2017 Aug 31;9(34):12727-12734. doi: 10.1039/c7nr00927e.

PMID:
28829093
13.

Assessment of Somatization and Medically Unexplained Symptoms in Later Life.

van Driel TJW, Hilderink PH, Hanssen DJC, de Boer P, Rosmalen JGM, Oude Voshaar RC.

Assessment. 2018 Apr;25(3):374-393. doi: 10.1177/1073191117721740. Epub 2017 Jul 26.

14.

Neurotrophic and inflammatory markers in bipolar disorder: A prospective study.

van den Ameele S, Coppens V, Schuermans J, De Boer P, Timmers M, Fransen E, Sabbe B, Morrens M.

Psychoneuroendocrinology. 2017 Oct;84:143-150. doi: 10.1016/j.psyneuen.2017.07.003. Epub 2017 Jul 5.

PMID:
28711724
15.

Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy.

van de Schoot AJAJ, de Boer P, Visser J, Stalpers LJA, Rasch CRN, Bel A.

Acta Oncol. 2017 May;56(5):667-674. doi: 10.1080/0284186X.2017.1287949. Epub 2017 Feb 20.

PMID:
28447562
16.

Differential Effects of Inflammatory and Psychosocial Stress on Mood, Hypothalamic-Pituitary-Adrenal Axis, and Inflammation in Remitted Depression.

Niemegeers P, De Boer P, Dumont GJH, Van Den Eede F, Fransen E, Claes SJ, Morrens M, Sabbe BGC.

Neuropsychobiology. 2016;74(3):150-158. doi: 10.1159/000466698. Epub 2017 Apr 27.

PMID:
28445888
17.

Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.

de Boer P, Jürgenliemk-Schulz IM, Westerveld H, de Leeuw AAC, Dávila-Fajardo R, Rasch CRN, Pieters BR, Stalpers LJA.

Radiother Oncol. 2017 May;123(2):306-311. doi: 10.1016/j.radonc.2017.04.005. Epub 2017 Apr 20.

PMID:
28434797
18.

Nanodiamonds as multi-purpose labels for microscopy.

Hemelaar SR, de Boer P, Chipaux M, Zuidema W, Hamoh T, Martinez FP, Nagl A, Hoogenboom JP, Giepmans BNG, Schirhagl R.

Sci Rep. 2017 Apr 7;7(1):720. doi: 10.1038/s41598-017-00797-2.

19.

Multi-color electron microscopy by element-guided identification of cells, organelles and molecules.

Scotuzzi M, Kuipers J, Wensveen DI, de Boer P, Hagen KC, Hoogenboom JP, Giepmans BN.

Sci Rep. 2017 Apr 7;7:45970. doi: 10.1038/srep45970.

20.

Is radical chemo-radiotherapy appropriate in patients with stage IV non-small-cell lung cancer due to cervical lymph node metastases?

de Boer P, Dahele MR, Senan S.

Ann Oncol. 2016 Oct;27(10):1973. doi: 10.1093/annonc/mdw267. Epub 2016 Aug 18. No abstract available.

PMID:
27543275

Supplemental Content

Loading ...
Support Center